Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apremilast in Cutaneous Dermatomyositis
NCT01140503Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Feb 2010
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apremilast in dermatomyositis (DM), sponsored by Stanford University. Started Feb 2010; status: terminated.
02
Drugs
apremilast
03
Conditions
dermatomyositis (DM)
Beyond the preview
Go deeper on NCT01140503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01140503.